Eduardo Vilanova

446 total citations
18 papers, 294 citations indexed

About

Eduardo Vilanova is a scholar working on Cell Biology, Surgery and Aquatic Science. According to data from OpenAlex, Eduardo Vilanova has authored 18 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cell Biology, 7 papers in Surgery and 5 papers in Aquatic Science. Recurrent topics in Eduardo Vilanova's work include Proteoglycans and glycosaminoglycans research (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Seaweed-derived Bioactive Compounds (5 papers). Eduardo Vilanova is often cited by papers focused on Proteoglycans and glycosaminoglycans research (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Seaweed-derived Bioactive Compounds (5 papers). Eduardo Vilanova collaborates with scholars based in Brazil, Germany and Spain. Eduardo Vilanova's co-authors include Paulo A.S. Mourão, Paulo Rodinei Soares Lopes, Ana Tovar, Gustavo Ramalho Cardoso dos Santos, M. S. Pereira, Bianca F. Glauser, Rafael Santos de Aquino, Ana Paula Valente, Juan José Valle‐Delgado and Paulo Antônio de Souza Mourão and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eduardo Vilanova

18 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Vilanova Brazil 10 108 104 64 52 51 18 294
Mohammad Matiur Rahman Bangladesh 14 54 0.5× 134 1.3× 240 3.8× 112 2.2× 20 0.4× 42 448
Chantal de Montigny Canada 7 12 0.1× 13 0.1× 115 1.8× 27 0.5× 19 0.4× 7 322
Donatella Mentino Italy 13 39 0.4× 20 0.2× 184 2.9× 4 0.1× 46 0.9× 29 399
Xiaoyun Yu China 14 32 0.3× 13 0.1× 292 4.6× 45 0.9× 13 0.3× 43 509
Yuta Baba Japan 8 7 0.1× 124 1.2× 46 0.7× 16 0.3× 12 0.2× 27 324
Su Ji Han China 10 21 0.2× 15 0.1× 106 1.7× 7 0.1× 25 0.5× 16 333
Maria Antonietta Ragusa Italy 11 10 0.1× 20 0.2× 117 1.8× 8 0.2× 17 0.3× 27 301
C. Aengus Murphy United States 9 29 0.3× 27 0.3× 128 2.0× 6 0.1× 36 0.7× 18 439
Jian Ning Liu China 12 12 0.1× 38 0.4× 112 1.8× 2 0.0× 18 0.4× 19 321
Xinyue Wang China 12 10 0.1× 67 0.6× 164 2.6× 7 0.1× 9 0.2× 38 409

Countries citing papers authored by Eduardo Vilanova

Since Specialization
Citations

This map shows the geographic impact of Eduardo Vilanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Vilanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Vilanova more than expected).

Fields of papers citing papers by Eduardo Vilanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Vilanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Vilanova. The network helps show where Eduardo Vilanova may publish in the future.

Co-authorship network of co-authors of Eduardo Vilanova

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Vilanova. A scholar is included among the top collaborators of Eduardo Vilanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Vilanova. Eduardo Vilanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Vilanova, Eduardo, et al.. (2023). Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers. Pharmaceutics. 15(4). 1115–1115. 6 indexed citations
2.
Tovar, Ana, et al.. (2022). Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors. SHILAP Revista de lepidopterología. 6(4). e309–e322. 9 indexed citations
3.
Tovar, Ana, et al.. (2022). Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin. TH Open. 6(2). e114–e123. 6 indexed citations
4.
Cabral, Lúcio Mendes, et al.. (2020). Insights on chemical-biological correlations learned from investigations on the sulfated galactan from the marine alga Bothryocladia occidentalis. International Journal of Biological Macromolecules. 158. 471–476. 5 indexed citations
5.
Vilanova, Eduardo, Bianca F. Glauser, Gustavo Ramalho Cardoso dos Santos, et al.. (2019). Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia. Frontiers in Medicine. 6. 16–16. 15 indexed citations
6.
Stelling, Mariana P., et al.. (2019). Methods for Isolation and Characterization of Sulfated Glycosaminoglycans from Marine Invertebrates. Methods in molecular biology. 1952. 55–70. 8 indexed citations
7.
Tovar, Ana, Bianca F. Glauser, Gustavo Ramalho Cardoso dos Santos, et al.. (2019). Converting the Distinct Heparins Sourced from Bovine or Porcine Mucosa into a Single Anticoagulant Drug. Thrombosis and Haemostasis. 119(4). 618–632. 12 indexed citations
8.
Cruz, Fernanda Ferreira, Vanessa Martins, Lígia Lins de Castro, et al.. (2018). Impact of Different Intratracheal Flows During Lung Decellularization on Extracellular Matrix Composition and Mechanics. Regenerative Medicine. 13(5). 519–530. 5 indexed citations
9.
Glauser, Bianca F., Gustavo Ramalho Cardoso dos Santos, Ana Tovar, et al.. (2018). Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine. Journal of Thrombosis and Haemostasis. 16(9). 1789–1799. 8 indexed citations
10.
Lopes, Paulo Rodinei Soares, Ana Paula Valente, Ana Tovar, et al.. (2018). A unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed α-fucose branches. Glycobiology. 28(8). 565–579. 34 indexed citations
11.
Mourão, Paulo A.S., Eduardo Vilanova, & Paulo Rodinei Soares Lopes. (2017). Unveiling the structure of sulfated fucose-rich polysaccharides via nuclear magnetic resonance spectroscopy. Current Opinion in Structural Biology. 50. 33–41. 40 indexed citations
12.
Santos, Gustavo Ramalho Cardoso dos, Bianca F. Glauser, Ana Tovar, et al.. (2017). Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine. Pharmaceuticals. 10(2). 38–38. 26 indexed citations
13.
Mourão, Paulo Antônio de Souza, et al.. (2017). A color‐code for glycosaminoglycans identification by means of polyacrylamide gel electrophoresis stained with the cationic carbocyanine dye Stains‐all. Electrophoresis. 39(4). 666–669. 15 indexed citations
15.
Vilanova, Eduardo, Gustavo Ramalho Cardoso dos Santos, Rafael Santos de Aquino, et al.. (2016). Carbohydrate-Carbohydrate Interactions Mediated by Sulfate Esters and Calcium Provide the Cell Adhesion Required for the Emergence of Early Metazoans. Journal of Biological Chemistry. 291(18). 9425–9437. 25 indexed citations
16.
Tovar, Ana, Gustavo Ramalho Cardoso dos Santos, Bianca F. Glauser, et al.. (2016). Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs. Scientific Reports. 6(1). 35619–35619. 30 indexed citations
17.
Vilanova, Eduardo, et al.. (2016). Update on Brazilian biosimilar enoxaparins. Expert Review of Hematology. 9(11). 1015–1021. 6 indexed citations
18.
Mayer‐Pinto, Mariana, et al.. (2012). How Much Is Too Little to Detect Impacts? A Case Study of a Nuclear Power Plant. PLoS ONE. 7(10). e47871–e47871. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026